{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T02:13:52Z","timestamp":1774577632023,"version":"3.50.1"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Divers"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1007\/s11030-021-10296-2","type":"journal-article","created":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T15:02:50Z","timestamp":1630508570000},"page":"1675-1695","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Drug repositioning for anti-tuberculosis drugs: an in silico polypharmacology approach"],"prefix":"10.1007","volume":"26","author":[{"given":"Sita Sirisha","family":"Madugula","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Selvaraman","family":"Nagamani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esther","family":"Jamir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lipsa","family":"Priyadarsinee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3181-7673","authenticated-orcid":false,"given":"G. Narahari","family":"Sastry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,9,1]]},"reference":[{"key":"10296_CR1","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.meegid.2014.05.031","volume":"26","author":"FD Huber","year":"2014","unstructured":"Huber FD, S\u00e1nchez A, Gomes HM, Vasconcellos S, Massari V, Barreto A, Cesconi V, de Almeida Machado SM, Gomgnimbou MK, Sola C, Larouz\u00e9 B, Suffys PN, Saad MH (2014) Insights into the population structure of Mycobacterium tuberculosis using spoligotyping and RDRio in a southeastern Brazilian prison unit. Infect Genet Evol 26:194\u2013202. https:\/\/doi.org\/10.1016\/j.meegid.2014.05.031","journal-title":"Infect Genet Evol"},{"key":"10296_CR2","unstructured":"WHO (2019) global tuberculosis report"},{"issue":"6","key":"10296_CR3","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1016\/j.bmc.2017.02.003","volume":"25","author":"M Krasavin","year":"2017","unstructured":"Krasavin M, Parchinsky V, Kantin G, Manicheva O, Dogonadze M, Vinogradova T, Br\u00f6nstrup M (2017) New nitrofurans amenable by isocyanide multicomponent chemistry are active against multidrug-resistant and poly-resistant Mycobacterium tuberculosis. Bioorg Med Chem 25(6):1867\u20131874. https:\/\/doi.org\/10.1016\/j.bmc.2017.02.003","journal-title":"Bioorg Med Chem"},{"issue":"9","key":"10296_CR4","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a017863","volume":"5","author":"KJ Seung","year":"2015","unstructured":"Seung KJ, Keshavjee S, Rich ML (2015) Multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis. Cold Spring Harb Perspect Med 5(9):a017863. https:\/\/doi.org\/10.1101\/cshperspect.a017863","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10296_CR5","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.chemphyslip.2013.12.004","volume":"180","author":"W Groenewald","year":"2014","unstructured":"Groenewald W, Baird MS, Verschoor JA, Minnikin DE, Croft AK (2014) Differential spontaneous folding of mycolic acids from Mycobacterium tuberculosis. Chem Phys Lipids 180:15\u201322. https:\/\/doi.org\/10.1016\/j.chemphyslip.2013.12.004","journal-title":"Chem Phys Lipids"},{"key":"10296_CR6","doi-asserted-by":"publisher","first-page":"307","DOI":"10.3389\/fimmu.2017.00307","volume":"8","author":"JM Scordo","year":"2017","unstructured":"Scordo JM, Arcos J, Kelley HV, Diangelo L, Sasindran SJ, Youngmin E, Wewers MD, Wang SH, Balada-Llasat JM, Torrelles JB (2017) Mycobacterium tuberculosis cell wall fragments released upon bacterial contact with the human lung mucosa alter the neutrophil response to infection. Front Immunol 8:307. https:\/\/doi.org\/10.3389\/fimmu.2017.00307","journal-title":"Front Immunol"},{"key":"10296_CR7","doi-asserted-by":"publisher","first-page":"17472","DOI":"10.1021\/acsomega.1c01865","volume":"6","author":"S Nagamani","year":"2021","unstructured":"Nagamani S, Sastry GN (2021) Mycobacterium tuberculosis (M.tb) cell wall permeability model generation using chemoinformatics and machine learning approaches. ACS Omega 6:17472\u201317482","journal-title":"ACS Omega"},{"issue":"5","key":"10296_CR8","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1007\/s12039-017-1268-4","volume":"129","author":"AS Gaur","year":"2017","unstructured":"Gaur AS, Bhardwaj A, Sharma A, John L, Vivek MR, Tripathi N, Bharatam PV, Kumar R, Janardhan S, Mori A, Banerji A (2017) Assessing therapeutic potential of molecules: molecular property diagnostic suite for tuberculosis (MPDSTB). J Chem Sci 129(5):515\u2013531. https:\/\/doi.org\/10.1007\/s12039-017-1268-4","journal-title":"J Chem Sci"},{"issue":"12","key":"10296_CR9","first-page":"753","volume":"81","author":"H Tomioka","year":"2006","unstructured":"Tomioka H, Namba K (2006) Development of antituberculosis drugs: current status and future prospects. Kekkaku 81(12):753\u201374","journal-title":"Kekkaku"},{"issue":"9","key":"10296_CR10","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1001\/jama.2020.1166","volume":"323","author":"OJ Wouters","year":"2020","unstructured":"Wouters OJ, McKee M, Luyten J (2020) Estimated research and development investment needed to bring a new medicine to market 2009\u20132018. JAMA 323(9):844\u2013853. https:\/\/doi.org\/10.1001\/jama.2020.1166","journal-title":"JAMA"},{"key":"10296_CR11","doi-asserted-by":"publisher","first-page":"112175","DOI":"10.1016\/j.ejmech.2020.112175","volume":"192","author":"Q An","year":"2020","unstructured":"An Q, Li C, Chen Y, Deng Y, Yang T, Luo Y (2020) Repurposed drug candidates for antituberculosis therapy. Eur J Med Chem 192:112175. https:\/\/doi.org\/10.1016\/j.ejmech.2020.112175","journal-title":"Eur J Med Chem"},{"issue":"13","key":"10296_CR12","doi-asserted-by":"publisher","first-page":"5633","DOI":"10.1007\/s00253-020-10606-y","volume":"104","author":"AA Adeniji","year":"2020","unstructured":"Adeniji AA, Knoll KE, Loots DT (2020) Potential anti-TB investigational compounds and drugs with repurposing potential in TB therapy: a conspectus. Appl Microbiol Biotechnol 104(13):5633\u20135662. https:\/\/doi.org\/10.1007\/s00253-020-10606-y","journal-title":"Appl Microbiol Biotechnol"},{"key":"10296_CR13","doi-asserted-by":"publisher","DOI":"10.1080\/07391102.2021.1905558","author":"N Kumar","year":"2021","unstructured":"Kumar N, Sarma H, Sastry GN (2021) Repurposing of approved drug molecules for viral infectious diseases: a molecular modelling approach. J Biomol Struct Dyn. https:\/\/doi.org\/10.1080\/07391102.2021.1905558","journal-title":"J Biomol Struct Dyn"},{"issue":"11","key":"10296_CR14","doi-asserted-by":"publisher","first-page":"3088","DOI":"10.1021\/ci300385h","volume":"52","author":"HK Srivastava","year":"2012","unstructured":"Srivastava HK, Sastry GN (2012) Molecular dynamics investigation on a series of HIV protease inhibitors: assessing the performance of MM-PBSA and MM-GBSA approaches. J Chem Inf Model 52(11):3088\u20133098. https:\/\/doi.org\/10.1021\/ci300385h","journal-title":"J Chem Inf Model"},{"issue":"10","key":"10296_CR15","doi-asserted-by":"publisher","first-page":"840","DOI":"10.2174\/138620711797537102","volume":"14","author":"P Badrinarayan","year":"2011","unstructured":"Badrinarayan P, Sastry GN (2011) Virtual high throughput screening in new lead identification. Comb Chem High Throughput Screen 14(10):840\u2013860. https:\/\/doi.org\/10.2174\/138620711797537102","journal-title":"Comb Chem High Throughput Screen"},{"issue":"4","key":"10296_CR16","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/j.ejmech.2007.06.009","volume":"43","author":"GK Ravindra","year":"2008","unstructured":"Ravindra GK, Achaiah G, Sastry GN (2008) Molecular modeling studies of phenoxypyrimidinyl imidazoles as p38 kinase inhibitors using QSAR and docking. Eur J Med Chem 43(4):830\u2013838. https:\/\/doi.org\/10.1016\/j.ejmech.2007.06.009","journal-title":"Eur J Med Chem"},{"key":"10296_CR17","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.jmgm.2011.12.009","volume":"34","author":"P Badrinarayan","year":"2012","unstructured":"Badrinarayan P, Sastry GN (2012) Virtual screening filters for the design of type II p38 MAP kinase inhibitors: a fragment based library generation approach. J Mol Graph Model 34:89\u2013100. https:\/\/doi.org\/10.1016\/j.jmgm.2011.12.009","journal-title":"J Mol Graph Model"},{"issue":"4","key":"10296_CR18","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1021\/ci500737b","volume":"55","author":"C Choudhury","year":"2015","unstructured":"Choudhury C, Priyakumar UD, Sastry GN (2015) Dynamics based pharmacophore models for screening potential inhibitors of mycobacterial cyclopropane synthase. J Chem Inf Model 55(4):848\u2013860. https:\/\/doi.org\/10.1021\/ci500737b","journal-title":"J Chem Inf Model"},{"issue":"7","key":"10296_CR19","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.4049\/jimmunol.1700525","volume":"203","author":"V Jha","year":"2019","unstructured":"Jha V, Rameshwaram NR, Janardhan S, Raman R, Sastry GN, Sharma V, Rao JS, Kumar D, Mukhopadhyay S (2019) Uncovering structural and molecular dynamics of ESAT-6: \u03b22M interaction: Asp53 of human \u03b22-microglobulin is critical for the ESAT-6: \u03b22M complexation. J Immunol 203(7):1918\u20131929. https:\/\/doi.org\/10.4049\/jimmunol.1700525","journal-title":"J Immunol"},{"issue":"4","key":"10296_CR20","doi-asserted-by":"publisher","first-page":"329","DOI":"10.2174\/138920307781369427","volume":"8","author":"AS Reddy","year":"2007","unstructured":"Reddy AS, Pati SP, Kumar PP, Pradeep HN, Sastry GN (2007) Virtual screening in drug discovery - a computational perspective. Curr Protein Pep Sci 8(4):329\u2013351","journal-title":"Curr Protein Pep Sci"},{"key":"10296_CR21","doi-asserted-by":"crossref","unstructured":"Nagamani S, Sahoo R, Muneeswaran G, Sastry GN (2019) Data science driven drug repurposing for metabolic disorders. In silico Drug Design 191\u2013227.","DOI":"10.1016\/B978-0-12-816125-8.00007-9"},{"key":"10296_CR22","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.jbi.2018.08.003","volume":"85","author":"AS Gaur","year":"2018","unstructured":"Gaur AS, Nagamani S, Tanneeru K, Druzhilovskiy D, Rudik A, Poroikov V, Sastry GN (2018) molecular property diagnostic suite for diabetes mellitus (MPDSDM): an integrated web portal for drug discovery and drug repurposing. J Biomed Inform 85:114\u2013125","journal-title":"J Biomed Inform"},{"issue":"9","key":"10296_CR23","doi-asserted-by":"publisher","first-page":"4263","DOI":"10.1007\/s00894-012-1416-1","volume":"18","author":"MH Bohari","year":"2012","unstructured":"Bohari MH, Sastry GN (2012) FDA approved drugs complexed to their targets: evaluating pose prediction accuracy of docking protocols. J Mol Model 18(9):4263\u20134274","journal-title":"J Mol Model"},{"issue":"1","key":"10296_CR24","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1080\/1062936X.2017.1408683","volume":"29","author":"RK Goel","year":"2018","unstructured":"Goel RK, Gawande DY, Lagunin AA, Poroikov VV (2018) Pharmacological repositioning of Achyranthes aspera as an antidepressant using pharmacoinformatic tools PASS and PharmaExpert: a case study with wet lab validation. SAR QSAR Environ Res 29(1):69\u201381. https:\/\/doi.org\/10.1080\/1062936X.2017.1408683","journal-title":"SAR QSAR Environ Res"},{"issue":"Database issue","key":"10296_CR25","doi-asserted-by":"publisher","first-page":"D901","DOI":"10.1093\/nar\/gkm958","volume":"36","author":"DS Wishart","year":"2008","unstructured":"Wishart DS, Knox C, Guo AC, Cheng D, Shrivastava S, Tzur D, Gautam B, Hassanali M (2008) DrugBank: a knowledgebase for drugs, drug actions and drug targets. Nucleic Acids Res 36(Database issue):D901\u2013D906. https:\/\/doi.org\/10.1093\/nar\/gkm958","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"10296_CR26","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1093\/nar\/28.1.235","volume":"28","author":"HM Berman","year":"2000","unstructured":"Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE (2000) The protein data bank. Nucleic Acids Res 28(1):235\u2013242. https:\/\/doi.org\/10.1093\/nar\/28.1.235","journal-title":"Nucleic Acids Res"},{"key":"10296_CR27","doi-asserted-by":"publisher","first-page":"5.6.1","DOI":"10.1002\/cpbi.3","volume":"54","author":"B Webb","year":"2016","unstructured":"Webb B, Sali A (2016) Comparative protein structure modeling using MODELLER. Curr Protoc Bioinform 54:5.6.1-5.6.37. https:\/\/doi.org\/10.1002\/cpbi.3","journal-title":"Curr Protoc Bioinform"},{"issue":"13","key":"10296_CR28","doi-asserted-by":"publisher","first-page":"4063","DOI":"10.1021\/jm9004016","volume":"52","author":"O G\u00fczel","year":"2009","unstructured":"G\u00fczel O, Maresca A, Scozzafava A, Salman A, Balaban AT, Supuran CT (2009) Discovery of low nanomolar and subnanomolar inhibitors of the mycobacterial beta-carbonic anhydrases Rv1284 and Rv3273. J Med Chem 52(13):4063\u20134067. https:\/\/doi.org\/10.1021\/jm9004016","journal-title":"J Med Chem"},{"issue":"9","key":"10296_CR29","doi-asserted-by":"publisher","first-page":"3116","DOI":"10.1021\/jm9003126","volume":"52","author":"I Nishimori","year":"2009","unstructured":"Nishimori I, Minakuchi T, Vullo D, Scozzafava A, Innocenti A, Supuran CT (2009) Carbonic anhydrase inhibitors Cloning, characterization, and inhibition studies of a new beta-carbonic anhydrase from Mycobacterium tuberculosis. J Med Chem 52(9):3116\u201320. https:\/\/doi.org\/10.1021\/jm9003126","journal-title":"J Med Chem"},{"issue":"29","key":"10296_CR30","doi-asserted-by":"publisher","first-page":"3300","DOI":"10.2174\/138161210793429814","volume":"16","author":"I Nishimori","year":"2010","unstructured":"Nishimori I, Minakuchi T, Maresca A, Carta F, Scozzafava A, Supuran CT (2010) The \u03b2-carbonic anhydrases from Mycobacterium tuberculosis as drug targets. Curr Pharm Des 16(29):3300\u20133309. https:\/\/doi.org\/10.2174\/138161210793429814","journal-title":"Curr Pharm Des"},{"key":"10296_CR31","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","volume":"1\u20132","author":"MJ Abraham","year":"2015","unstructured":"Abraham MJ, Murtola T, Schulz R, P\u00e1ll S, Smith JC, Hess B, Lindahl E (2015) GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX 1\u20132:19\u201325. https:\/\/doi.org\/10.1016\/j.softx.2015.06.001","journal-title":"SoftwareX"},{"issue":"3","key":"10296_CR32","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1002\/prot.10286","volume":"50","author":"SC Lovell","year":"2003","unstructured":"Lovell SC, Davis IW, Arendall WB 3rd, de Bakker PI, Word JM, Prisant MG, Richardson JS, Richardson DC (2003) Structure validation by Calpha geometry: phi, psi and Cbeta deviation. Proteins 50(3):437\u2013450. https:\/\/doi.org\/10.1002\/prot.10286","journal-title":"Proteins"},{"issue":"2","key":"10296_CR33","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/jcc.21334","volume":"31","author":"O Trott","year":"2010","unstructured":"Trott O, Olson AJ (2010) AutoDock Vina: improve ng the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem 31(2):455\u2013461. https:\/\/doi.org\/10.1002\/jcc.21334","journal-title":"J Comput Chem"},{"issue":"8","key":"10296_CR34","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1093\/bioinformatics\/16.8.747","volume":"16","author":"A Lagunin","year":"2000","unstructured":"Lagunin A, Stepanchikova A, Filimonov D, Poroikov V (2000) PASS: prediction of activity spectra for biologically active substances. Bioinformatics 16(8):747\u2013748. https:\/\/doi.org\/10.1093\/bioinformatics\/16.8.747","journal-title":"Bioinformatics"},{"key":"10296_CR35","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1007\/s10593-014-1496-1","volume":"50","author":"DA Filimonov","year":"2014","unstructured":"Filimonov DA, Lagunin AA, Gloriozova TA, Rudik AV, Druzhilovskiy DS, Pogodin PV, Poroikov VV (2014) Prediction of the biological activity spectra of organic compounds using the pass online web resource. Chem Heterocycl Compd 50:444\u2013457. https:\/\/doi.org\/10.1007\/s10593-014-1496-1","journal-title":"Chem Heterocycl Compd"},{"key":"10296_CR36","unstructured":"http:\/\/www.niper.gov.in\/pi_dev_tools\/DruLiToWeb\/DruLiTo_Reference.html"},{"issue":"5","key":"10296_CR37","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1006\/jmbi.2000.4094","volume":"302","author":"AM Baca","year":"2000","unstructured":"Baca AM, Sirawaraporn R, Turley S, Sirawaraporn W, Houl WG (2000) Crystal structure of Mycobacterium tuberculosis 7,8-dihydropteroate synthase in complex with pterin monophosphate: new insight into the enzymatic mechanism and sulfa-drug action. J Mol Biol 302(5):1193\u20131212","journal-title":"J Mol Biol"},{"issue":"10","key":"10296_CR38","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1080\/1062936X.2017","volume":"28","author":"S Janardhan","year":"2017","unstructured":"Janardhan S, John L, Prasanthi M, Poroikov V, Narahari Sastry G (2017) A QSAR and molecular modelling study towards new lead finding: polypharmacological approach to Mycobacterium tuberculosis. SAR QSAR Environ Res 28(10):815\u2013832. https:\/\/doi.org\/10.1080\/1062936X.2017","journal-title":"SAR QSAR Environ Res"},{"issue":"4","key":"10296_CR39","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/S1473-3099(13)70328-1","volume":"14","author":"AI Zumla","year":"2014","unstructured":"Zumla AI, Gillespie SH, Hoelscher M, Philips PP, Cole ST, Abubakar I, McHugh TD, Schito M, Maeurer M, Nunn AJ (2014) New ant tuberculosis drugs, regimens, and adjunct therapies: needs, advances, and future prospects. Lancet Infect Dis 14(4):327\u2013340. https:\/\/doi.org\/10.1016\/S1473-3099(13)70328-1","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"10296_CR40","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1378\/chest.88.5.726","volume":"88","author":"CE Davis","year":"1985","unstructured":"Davis CE, Carpenter JL, McAllister CK, Matthews J, Bush BA, Ognibene AJ (1985) Tuberculosis. Cause of death in antibiotic era. Chest 88(5):726\u2013729. https:\/\/doi.org\/10.1378\/chest.88.5.726","journal-title":"Chest"},{"issue":"22","key":"10296_CR41","doi-asserted-by":"publisher","first-page":"15582","DOI":"10.1074\/jbc.274.22.15582","volume":"274","author":"DA Rozwarski","year":"1999","unstructured":"Rozwarski DA, Vilch\u00e8ze C, Sugantino M, Bittman R, Sacchettini JC (1999) Crystal structure of the Mycobacterium tuberculosis enoyl-ACP reductase, InhA, in complex with NAD+ and a C16 fatty acyl substrate. J Biol Chem. 274(22):15582\u20139. https:\/\/doi.org\/10.1074\/jbc.274.22.15582","journal-title":"J Biol Chem."},{"issue":"2","key":"10296_CR42","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1006\/jmbi.1999.3328","volume":"295","author":"R Li","year":"2000","unstructured":"Li R, Sirawaraporn R, Chitnumsub P, Sirawaraporn W, Wooden J, Athappilly F, Turley S, Hol WG (2000) Three-dimensional structure of M. tuberculosis dihydrofolate reductase reveals opportunities for the design of novel tuberculosis drugs. J Mol Biol 295(2):307\u201323. https:\/\/doi.org\/10.1006\/jmbi.1999.3328","journal-title":"J Mol Biol"},{"issue":"36","key":"10296_CR43","doi-asserted-by":"publisher","first-page":"10644","DOI":"10.1021\/bi030044v","volume":"42","author":"M Cirilli","year":"2003","unstructured":"Cirilli M, Zheng R, Scapin G, Blanchard JS (2003) The three-dimensional structures of the Mycobacterium tuberculosis dihydrodipicolinate reductase-NADH-2,6-PDC and -NADPH-2,6-PDC complexes. Structural and mutagenic analysis of relaxed nucleotide specificity. Biochemistry 42(36):10644\u201350. https:\/\/doi.org\/10.1021\/bi030044v","journal-title":"Biochemistry"},{"issue":"23","key":"10296_CR44","doi-asserted-by":"publisher","first-page":"8662","DOI":"10.1073\/pnas.0510436103","volume":"103","author":"Q Ma","year":"2006","unstructured":"Ma Q, Zhao X, Nasser Eddine A, Geerlof A, Li X, Cronan JE, Kaufmann SH, Wilmanns M (2006) The Mycobacterium tuberculosis LipB enzyme functions as a cysteine\/lysine dyad acyltransferase. Proc Natl Acad Sci U S A 103(23):8662\u20138667. https:\/\/doi.org\/10.1073\/pnas.0510436103","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"10296_CR45","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1021\/bi0486583","volume":"44","author":"P LeMagueres","year":"2005","unstructured":"LeMagueres P, Im H, Ebalunode J, Strych U, Benedik MJ, Briggs JM, Kohn H, Krause KL (2005) The 1.9 A crystal structure of alanine racemase from Mycobacterium tuberculosis contains a conserved entryway into the active site. Biochemistry 44(5):1471\u201381. https:\/\/doi.org\/10.1021\/bi0486583","journal-title":"Biochemistry"},{"issue":"6","key":"10296_CR46","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1128\/JB.187.6.2175-2181","volume":"187","author":"C Madhurantakam","year":"2005","unstructured":"Madhurantakam C, Rajakumara E, Mazumdar PA, Saha B, Mitra D, Wiker HG, Sankaranarayanan R, Das AK (2005) Crystal structure of low-molecular-weight protein tyrosine phosphatase from Mycobacterium tuberculosis at 1.9-A resolution. J Bacteriol 187(6):2175\u201381. https:\/\/doi.org\/10.1128\/JB.187.6.2175-2181","journal-title":"J Bacteriol"},{"issue":"19","key":"10296_CR47","doi-asserted-by":"publisher","first-page":"18782","DOI":"10.1074\/jbc.M414348200","volume":"280","author":"AS Covarrubias","year":"2005","unstructured":"Covarrubias AS, Larsson AM, H\u00f6gbom M, Lindberg J, Bergfors T, Bj\u00f6rkelid C, Mowbray SL, Unge T, Jones TA (2005) Structure and function of carbonic anhydrases from Mycobacterium tuberculosis. J Biol Chem 280(19):18782\u201318789. https:\/\/doi.org\/10.1074\/jbc.M414348200","journal-title":"J Biol Chem"},{"issue":"28","key":"10296_CR48","doi-asserted-by":"publisher","first-page":"11354","DOI":"10.1073\/pnas.1205735109","volume":"109","author":"SM Batt","year":"2012","unstructured":"Batt SM, Jabeen T, Bhowruth V, Quill L, Lund PA, Eggeling L, Alderwick LJ, F\u00fctterer K, Besra GS (2012) Structural basis of inhibition of Mycobacterium tuberculosis DprE1 by benzothiazinone inhibitors. Proc Natl Acad Sci U S A 109(28):11354\u201311359. https:\/\/doi.org\/10.1073\/pnas.1205735109","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"34","key":"10296_CR49","doi-asserted-by":"publisher","first-page":"30273","DOI":"10.1074\/jbc.M503780200","volume":"280","author":"SK Srivastava","year":"2005","unstructured":"Srivastava SK, Tripathi RP, Ramachandran R (2005) NAD+-dependent DNA Ligase (Rv3014c) from Mycobacterium tuberculosis. Crystal structure of the adenylation domain and identification of novel inhibitors. J Biol Chem 280(34):30273\u201381. https:\/\/doi.org\/10.1074\/jbc.M503780200","journal-title":"J Biol Chem"},{"issue":"13","key":"10296_CR50","doi-asserted-by":"publisher","first-page":"3018","DOI":"10.1016\/j.febslet.2006.04.046","volume":"580","author":"A Wehenkel","year":"2006","unstructured":"Wehenkel A, Fernandez P, Bellinzoni M, Catherinot V, Barilone N, Labesse G, Jackson M, Alzari PM (2006) The structure of PknB in complex with mitoxantrone, an ATP-competitive inhibitor, suggests a mode of protein kinase regulation in mycobacteria. FEBS Lett 580(13):3018\u20133022. https:\/\/doi.org\/10.1016\/j.febslet.2006.04.046","journal-title":"FEBS Lett"},{"issue":"5","key":"10296_CR51","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/j.jmb.2006.08.019","volume":"362","author":"SM Tripathi","year":"2006","unstructured":"Tripathi SM, Ramachandran R (2006) Direct evidence for a glutamate switch necessary for substrate recognition: crystal structures of lysine epsilon-aminotransferase (Rv3290c) from Mycobacterium tuberculosis H37Rv. J Mol Biol 362(5):877\u2013886. https:\/\/doi.org\/10.1016\/j.jmb.2006.08.019","journal-title":"J Mol Biol"},{"issue":"7","key":"10296_CR52","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1016\/j.str.2009.04.012","volume":"17","author":"SR Luckner","year":"2009","unstructured":"Luckner SR, Machutta CA, Tonge PJ, Kisker C (2009) Crystal structures of Mycobacterium tuberculosis KasA show mode of action within cell wall biosynthesis and its inhibition by thiolactomycin. Structure 17(7):1004\u20131013. https:\/\/doi.org\/10.1016\/j.str.2009.04.012","journal-title":"Structure"},{"issue":"6","key":"10296_CR53","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1021\/bi051873e","volume":"45","author":"S Wang","year":"2006","unstructured":"Wang S, Eisenberg D (2006) Crystal structure of the pantothenate synthetase from Mycobacterium tuberculosis, snapshots of the enzyme in action. Biochemistry 45(6):1554\u20131561. https:\/\/doi.org\/10.1021\/bi051873e (PMID: 16460002)","journal-title":"Biochemistry"},{"issue":"27","key":"10296_CR54","doi-asserted-by":"publisher","first-page":"19905","DOI":"10.1074\/jbc.M701935200","volume":"282","author":"LM Henriksson","year":"2007","unstructured":"Henriksson LM, Unge T, Carlsson J, Aqvist J, Mowbray SL, Jones TA (2007) Structures of Mycobacterium tuberculosis 1-deoxy-D-xylulose-5-phosphate reductoisomerase provide new insights into catalysis. J Biol Chem 282(27):19905\u201319916. https:\/\/doi.org\/10.1074\/jbc.M701935200","journal-title":"J Biol Chem"},{"issue":"4","key":"10296_CR55","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.chembiol.2008.03.007","volume":"15","author":"S Sachdeva","year":"2008","unstructured":"Sachdeva S, Musayev FN, Alhamadsheh MM, Scarsdale JN, Wright HT, Reynolds KA (2008) Separate entrance and exit portals for ligand traffic in Mycobacterium tuberculosis FabH. Chem Biol 15(4):402\u2013412. https:\/\/doi.org\/10.1016\/j.chembiol.2008.03.007","journal-title":"Chem Biol"},{"issue":"Pt 3","key":"10296_CR56","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1107\/S0907444909001036","volume":"65","author":"Z Zhang","year":"2009","unstructured":"Zhang Z, Bulloch EM, Bunker RD, Baker EN, Squire CJ (2009) Structure and function of GlmU from Mycobacterium tuberculosis. Acta Crystallogr D Biol Crystallogr 65(Pt 3):275\u2013283. https:\/\/doi.org\/10.1107\/S0907444909001036","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"issue":"6","key":"10296_CR57","doi-asserted-by":"publisher","first-page":"3068","DOI":"10.1073\/pnas.061562898","volume":"98","author":"LM Podust","year":"2001","unstructured":"Podust LM, Poulos TL, Waterman MR (2001) Crystal structure of cytochrome P450 14alpha -sterol demethylase (CYP51) from Mycobacterium tuberculosis in complex with azole inhibitors. Proc Natl Acad Sci U S A 98(6):3068\u20133073. https:\/\/doi.org\/10.1073\/pnas.061562898","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10296_CR58","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1021\/bi0484163","volume":"44","author":"E Fioravanti","year":"2005","unstructured":"Fioravanti E, Adam V, Munier-Lehmann H, Bourgeois D (2005) The crystal structure of Mycobacterium tuberculosis thymidylate kinase in complex with 3\u2019-azidodeoxythymidine monophosphate suggests a mechanism for competitive inhibition. Biochemistry 44(1):130\u2013137. https:\/\/doi.org\/10.1021\/bi0484163","journal-title":"Biochemistry"},{"issue":"5","key":"10296_CR59","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1006\/jmbi.2000.4094","volume":"302","author":"AM Baca","year":"2000","unstructured":"Baca AM, Sirawaraporn R, Turley S, Sirawaraporn W, Hol WG (2000) Crystal structure of Mycobacterium tuberculosis 7,8-dihydropteroate synthase in complex with pterin monophosphate: new insight into the enzymatic mechanism and sulfa-drug action. J Mol Biol 302(5):1193\u20131212. https:\/\/doi.org\/10.1006\/jmbi.2000.4094","journal-title":"J Mol Biol"},{"issue":"140","key":"10296_CR60","doi-asserted-by":"publisher","first-page":"1050902","DOI":"10.1016\/j.ejps.2019.105092","volume":"1","author":"NH Zuma","year":"2019","unstructured":"Zuma NH, Aucamp J, N\u2019Da DD (2019) An update on derivatisation and repurposing of clinical nitrofuran drugs. Eur J Pharm Sci 1(140):1050902. https:\/\/doi.org\/10.1016\/j.ejps.2019.105092","journal-title":"Eur J Pharm Sci"},{"issue":"9","key":"10296_CR61","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.3390\/nu10091267","volume":"10","author":"F La Rosa","year":"2018","unstructured":"La Rosa F, Clerici M, Ratto D, Occhinegro A, Licito A, Romeo M, Rossi P (2018) The gut-brain axis in Alzheimer\u2019s disease and Omega-3 A critical overview of clinical trials. Nutrients 10(9):1267. https:\/\/doi.org\/10.3390\/nu10091267","journal-title":"Nutrients"},{"issue":"255","key":"10296_CR62","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.virusres.2018.07.018","volume":"15","author":"S Malakar","year":"2018","unstructured":"Malakar S, Sreelatha L, Dechtawewat T, Noisakran S, Yenchitsomanus PT, Chu JJH, Limjindaporn T (2018) Drug repurposing of quinine as antiviral against dengue virus infection. Virus Res 15(255):171\u2013178. https:\/\/doi.org\/10.1016\/j.virusres.2018.07.018","journal-title":"Virus Res"},{"issue":"7","key":"10296_CR63","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1038\/nrd.2017","volume":"16","author":"JW Murrough","year":"2017","unstructured":"Murrough JW, Abdallah CG, Mathew SJ (2017) Targeting glutamate signalling in depression: progress and prospects. Nat Rev Drug Discov 16(7):472\u2013486. https:\/\/doi.org\/10.1038\/nrd.2017","journal-title":"Nat Rev Drug Discov"},{"issue":"9","key":"10296_CR64","doi-asserted-by":"publisher","first-page":"2521","DOI":"10.1080\/07391102.2019.1637280","volume":"38","author":"J Rani","year":"2020","unstructured":"Rani J, Silla Y, Borah K, Ramachandran S, Bajpai U (2020) Repurposing of FDA-approved drugs to target MurB and MurE enzymes in Mycobacterium tuberculosis. J Biomol Struct Dyn 38(9):2521\u20132532. https:\/\/doi.org\/10.1080\/07391102.2019.1637280","journal-title":"J Biomol Struct Dyn"}],"container-title":["Molecular Diversity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-021-10296-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11030-021-10296-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-021-10296-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,20]],"date-time":"2022-06-20T14:05:35Z","timestamp":1655733935000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11030-021-10296-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,1]]},"references-count":64,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["10296"],"URL":"https:\/\/doi.org\/10.1007\/s11030-021-10296-2","relation":{},"ISSN":["1381-1991","1573-501X"],"issn-type":[{"value":"1381-1991","type":"print"},{"value":"1573-501X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,1]]},"assertion":[{"value":"24 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}